Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by NorthRock Partners LLC

NorthRock Partners LLC trimmed its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 53.9% during the third quarter, Holdings Channel reports. The firm owned 414 shares of the medical instruments supplier’s stock after selling 485 shares during the quarter. NorthRock Partners LLC’s holdings in Mettler-Toledo International were worth $621,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of MTD. Family Firm Inc. acquired a new stake in shares of Mettler-Toledo International in the 2nd quarter worth about $25,000. Blue Trust Inc. lifted its position in Mettler-Toledo International by 242.9% in the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 17 shares during the last quarter. Rothschild Investment LLC bought a new stake in Mettler-Toledo International in the 2nd quarter valued at about $42,000. Itau Unibanco Holding S.A. bought a new stake in Mettler-Toledo International in the 2nd quarter valued at about $42,000. Finally, Crewe Advisors LLC lifted its position in Mettler-Toledo International by 244.4% in the 2nd quarter. Crewe Advisors LLC now owns 31 shares of the medical instruments supplier’s stock valued at $43,000 after purchasing an additional 22 shares during the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,385.79 on Wednesday. Mettler-Toledo International Inc. has a twelve month low of $953.28 and a twelve month high of $1,546.93. The firm has a market cap of $29.41 billion, a PE ratio of 38.13, a P/E/G ratio of 3.92 and a beta of 1.16. The firm’s 50 day moving average price is $1,401.48 and its two-hundred day moving average price is $1,399.41.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on MTD. JPMorgan Chase & Co. lifted their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. Wells Fargo & Company started coverage on shares of Mettler-Toledo International in a research report on Tuesday, August 27th. They issued an “equal weight” rating and a $1,400.00 price objective on the stock. StockNews.com upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Thursday, July 11th. Evercore ISI boosted their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Finally, Stifel Nicolaus boosted their price target on shares of Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the stock a “buy” rating in a research report on Monday, August 5th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat, Mettler-Toledo International currently has a consensus rating of “Hold” and an average target price of $1,363.75.

Insider Activity

In related news, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the completion of the sale, the insider now owns 734 shares of the company’s stock, valued at approximately $1,044,459.98. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.94% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.